Oakworth Capital’s St Jude Medical STJ Stock Holding History

Oakworth Capital’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-66	Closed	-$5K	–	687
2016 Q4	$5K	Hold	66	–	–	﹤0.01%	538
2016 Q3	$5K	Hold	66	–	–	﹤0.01%	512
2016 Q2	$5K	Hold	66	–	–	﹤0.01%	488
2016 Q1	$4K	Hold	66	–	–	﹤0.01%	458
2015 Q4	$4K	Hold	66	–	–	﹤0.01%	437
2015 Q3	$4K	Hold	66	–	–	﹤0.01%	361
2015 Q2	$5K	Hold	66	–	–	﹤0.01%	355
2015 Q1	$5K	Hold	66	–	–	﹤0.01%	364
2014 Q4	$4K	Hold	66	–	–	﹤0.01%	379
2014 Q3	$4K	Hold	66	–	–	﹤0.01%	351
2014 Q2	$5K	Hold	66	–	–	﹤0.01%	339
2014 Q1	$4K	Hold	66	–	–	﹤0.01%	359
2013 Q4	$4K	Buy	+66	New	+$3.82K	﹤0.01%	342

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Oakworth Capital's STJ Position: Q1 2017 in Review

Oakworth Capital sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 66 shares — an estimated $5K sold.

Oakworth Capital first reported a position in STJ in Q4 2013 and held it in 13 quarters. The position peaked at $5K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Oakworth Capital reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Oakworth Capital sold 66 St Jude Medical shares in Q1 2017, an estimated $5K.
Oakworth Capital first reported a position in St Jude Medical in Q4 2013 and held it in 13 quarters.
Oakworth Capital's St Jude Medical position peaked at $5K in Q4 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Oakworth Capital's 13F filing for Q1 2017, filed 26 Apr 2017.